City

Kathmandu (1)

Los Angeles (1)

Rotterdam (1)

West Des Moines (1)

Condition

Nuclear Cataract (4)

Anterior Chamber Inflammation (1)

Cataract Senile (1)

Corneal Defect (1)

Corneal Edema (1)

Cortical Cataract (1)

Ocular Pain (1)

Penetrating KeratoPlasty (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Chakshu Research, Inc. (1)

Matthew Rauen (1)

Nicole Fram M.D. (1)

Oogziekenhuis Rotterdam (1)

Collaborator

Carl Zeiss Meditec AG (1)

Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis Prof.dr H.J. Flieringa (1)

Intervention

c-kad ophthalmic solution (1)

dextenza 0.4mg ophthalmic insert (1)

high iop (1)

lens fragmentation (1)

liquitears (1)

low iop (1)

Study Documents

Intervention Type

drug (2)

device (1)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (2)

Observational (2)

nuclear cataract

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Phacoemulsification at High IOP and Physiologic IOP: Impact on

Recruiting

Nuclear Cataract

High IOP
Low IOP

West Des Moines, Iowa

Wolfe Eye Clinic

Feb 28, 2023

Nuclear Cataract Trial in Rotterdam (Lens fragmentation)

Not yet recruiting

Nuclear Cataract

Lens fragmentation

Rotterdam, Netherlands

Oogziekenhuis Rotterdam

Feb 9, 2023

DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract

Completed

Anterior Chamber Inflammation
+7 more

Dextenza 0.4Mg Ophthalmic Insert

Los Angeles, California

Advanced Vision Care

Jul 14, 2021

Nuclear Cataract Trial in Kathmandu (LiquiTears, C-KAD Ophthalmic Solution)

Unknown status

Nuclear Cataract

LiquiTears
C-KAD Ophthalmic Solution

Kathmandu, Nepal

Tilganga Eye Center

Jan 20, 2009